Becton Dickinson offers EU concessions over $24 billion Bard deal
The deal, announced in April, is the latest in the medical device sector as companies seek to offset slowing revenue growth, consolidation among healthcare providers and rising pressure from customers to hold down treatment costs.
Becton Dickinson submitted its concessions on Sept. 27, a filing on the EU competition authority showed. It did not provide details, in line with its policy.
The Commission extended its deadline for a decision to October 18 from October 4. It can demand more concessions or open a full-scale investigation of about four months if the companies fail to allay its concerns. ■